000 01170 a2200349 4500
005 20250515032205.0
264 0 _c20061212
008 200612s 0 0 eng d
022 _a0387-7604
024 7 _a10.1016/j.braindev.2006.05.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMazzone, Luigi
245 0 0 _aTopiramate in children with autistic spectrum disorders.
_h[electronic resource]
260 _bBrain & development
_cNov 2006
300 _a668 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Letter; Comment
650 0 4 _aAdolescent
650 0 4 _aAutistic Disorder
_xdrug therapy
650 0 4 _aChild
650 0 4 _aDrug Administration Schedule
650 0 4 _aFollow-Up Studies
650 0 4 _aFructose
_xanalogs & derivatives
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeuroprotective Agents
_xtherapeutic use
650 0 4 _aTime Factors
650 0 4 _aTopiramate
650 0 4 _aTreatment Outcome
700 1 _aRuta, Liliana
773 0 _tBrain & development
_gvol. 28
_gno. 10
_gp. 668
856 4 0 _uhttps://doi.org/10.1016/j.braindev.2006.05.004
_zAvailable from publisher's website
999 _c16391263
_d16391263